Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (NY:ATNM)

1.130 +0.070 (+6.60%)

Official Closing Price Updated: 6:30 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Actinium Pharmaceuticals, Inc. (Delaware) Common Stock

< Previous 1 2 3 4 5 Next >

Actinium Pharma Cratered 37% Over Two Days — Here's Why, According To CEO Sandesh Seth ↗

February 24, 2023

Actinium CEO Sandesh Seth says the tumble this week had little to do with clinical data.

Via Investor's Business Daily

Global Market for Acute Myeloid Leukemia Expected to Reach $3.2 Billion By 2029

February 22, 2023

EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:AZN),(NYSE:BMY),(NYSE:AMAM),(NYSE:GSK) EQNX::TICKER_END

Via FinancialNewsMedia

Actinium Announces Positive Full Data Results From the Pivotal Phase 3 SIERRA Trial in Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia

February 22, 2023

– Iomab-B met the primary endpoint of durable Complete Remission (dCR) of 6-months following initial complete remission after BMT with high statistical significance (p-value of <0.0001), 22% of...

Via FinancialNewsMedia

Actinium Shares Are Trading Higher After Positive Data From Acute Myeloid Leukemia Trial ↗

October 31, 2022

Via Benzinga

With Upcoming Pivotal Data, Analyst Sees 145% Upside In Actinium ↗

September 08, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023 ↗

February 21, 2023

Via Benzinga

What's Going On With Actinium Pharmaceuticals Stock? ↗

February 21, 2023

Actinium Pharmaceuticals Inc (AMEX:ATNM) shares are trading higher Tuesday after the company announced full data results from the pivotal Phase 3 SIERRA trial in patients with active, relapsed or...

Via Benzinga

Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket ↗

February 21, 2023

Gainers Troika Media Group Inc (NASDAQ: TRKA) shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 21, 2023

It's time to start another day of trading with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday!

Via InvestorPlace

Actinium Pharmaceuticals’ Shares Stay Bullish Ahead Of Expected Topline Phase 3 Data Release In Q4 ($ATNM)

December 12, 2022

Via AB Newswire

Actinium Pharmaceuticals’ Shares Rally Ahead Of Topline Phase 3 Data Release; Update Expected By Year’s End ($ATNM)

December 08, 2022

Via AB Newswire

Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday ↗

November 23, 2022

U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday ↗

November 23, 2022

Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on...

Via Benzinga

Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session ↗

November 22, 2022

Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel...

Via Benzinga

4 Analysts Have This to Say About Actinium Pharmaceuticals ↗

October 31, 2022

Over the past 3 months, 4 analysts have published their opinion on Actinium Pharmaceuticals (AMEX:ATNM) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

Why Is Getty Images (GETY) Stock Up 33% Today? ↗

October 31, 2022

Getty Images (GETY) stock is rising higher on Monday with heavy trading despite a lack of news concerning the company today.

Via InvestorPlace

Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday ↗

November 01, 2022

Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...

Via Benzinga

PERF Stock Soars 21% on First Trading Day ↗

October 31, 2022

Perfect (PERF) stock is taking off on Monday as investors pump shares higher on their first day of trading after a SPAC merger.

Via InvestorPlace

Actinium (ATNM) Stock Pops on Positive Trial Results ↗

October 31, 2022

Actinium Pharmaceuticals (ATNM) stock is gaining on Monday after posting positive results from a Phase 3 clinical trial.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 31, 2022

Welcome back and get ready for another week of trading as we break down the biggest pre-market stock movers for Monday morning!

Via InvestorPlace

Actinium Pharmaceuticals’ Q4 Phase 3 Trial Updates Could Make Expected Milestones 2023 Catalysts ($ATNM)

October 26, 2022

Via AB Newswire

Actinium Pharmaceuticals’ Investor Update Puts Clinical Milestones And Potential Catalysts In The Crosshairs ($ATNM)

October 24, 2022

Via AB Newswire

Top Cheap Stocks: Trading Opportunities For Next Week ↗

April 24, 2022

A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Let's look at some cheap stock opportunities by analyzing...

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022 ↗

September 08, 2022

Via Benzinga

Biotech Stocks News: What’s Going on With LIXT, PTE, QLGN and ATNM Stocks Today? ↗

April 12, 2022

Biotech stocks are up today amid an influx of positive news. Here's what investors need to know as these small companies skyrocket.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗

August 25, 2022

Upgrades

Via Benzinga

Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More ↗

April 12, 2022

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...

Via Benzinga

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More ↗

April 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why Actinium Pharmaceuticals Stock Is Surging ↗

April 12, 2022

Actinium Pharmaceuticals Inc (AMEX:ATNM) shares are trading higher Tuesday morning after the company announced it entered into a license and supply agreement with Immedica...

Via Benzinga

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.